Ali Capital

Ali Capital is a personal investment vehicle established by Suleman "Suli" Ali in 2018. Based in San Francisco, California, the company focuses on investing in early-stage technology startups, particularly in the software and information technology sectors. Through its investments, Ali Capital aims to support and foster innovation within the tech industry.

Suleman Ali

Investor

4 past transactions

sync.labs

Seed Round in 2024
We’re a team of artists, engineers, and researchers building controllable AI video editing tools to unbound human creative potential. Our research team build AI video models to understand and affect fine-grained, controllable edits over any human in any video. Our product team makes these models accessible to editors, animators, developers, and businesses to edit and repurpose any video for any audience. Our technology is used to automate lip-dubbing in localization processes in entertainment, create dynamic marketing campaigns personalized to individuals or communities, animate new characters to life in minutes instead of days, affect word-level edits in studio-grade videos to fix mistakes in post-production avoiding having to rerecord entire scenes, and more. Our models are used by everyday people, prosumers, developers, and businesses large and small to tell outstanding stories. In just the last year we graduated at the top of our YC batch (W24), raised a $5.5M seed backed by GV, won the AI grant from Nat Friedman and Daniel Gross, scaled to millions in revenue – and this is only the beginning.

OmniVis

Seed Round in 2021
OmniVis is a biotechnology company that has created an integrated portable platform for the detection of pathogens in various environments, including food processing facilities. The company offers a handheld device that quantitatively measures pathogens, providing accurate results in under 30 minutes. This technology utilizes single-use disposable test kits that analyze swabs or liquid samples, significantly reducing the time and labor associated with traditional lab testing. By delivering a low-cost and user-friendly solution, OmniVis enables health organizations to enhance their pathogen detection capabilities effectively.

Postscript

Series B in 2021
Postscript is an eCommerce SMS platform that facilitates communication between brands and their customers through text message marketing. By allowing users to create and manage SMS marketing campaigns, the platform helps businesses engage effectively with their audience. It offers features such as detailed analytics and message automation based on customer interactions, which assist in optimizing campaigns for better sales outcomes. Postscript aims to address the challenges of declining email engagement by providing a more direct and customizable marketing channel through SMS, thereby enhancing customer engagement and driving revenue growth for eCommerce businesses.

Postscript

Seed Round in 2019
Postscript is an eCommerce SMS platform that facilitates communication between brands and their customers through text message marketing. By allowing users to create and manage SMS marketing campaigns, the platform helps businesses engage effectively with their audience. It offers features such as detailed analytics and message automation based on customer interactions, which assist in optimizing campaigns for better sales outcomes. Postscript aims to address the challenges of declining email engagement by providing a more direct and customizable marketing channel through SMS, thereby enhancing customer engagement and driving revenue growth for eCommerce businesses.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.